Alistair Macdonald - 02 Mar 2022 Form 4 Insider Report for Syneos Health, Inc. (SYNH)

Role
Chief Executive Officer, Director
Signature
/s/ Sara Epstein, Attorney-in-Fact
Issuer symbol
SYNH
Transactions as of
02 Mar 2022
Transactions value $
-$2,160,951
Form type
4
Filing time
04 Mar 2022, 16:06:38 UTC
Previous filing
20 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SYNH Class A Common Stock Award $0 +36,727 +18% $0 237,803 02 Mar 2022 Direct F1
transaction SYNH Class A Common Stock Award $0 +8,209 +3.5% $0 246,012 02 Mar 2022 Direct F2
transaction SYNH Class A Common Stock Award $0 +8,880 +3.6% $0 254,892 02 Mar 2022 Direct F3
transaction SYNH Class A Common Stock Tax liability -$2,160,950 -26,761 -10% $80.75 228,131 02 Mar 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents performance restricted stock units that were earned based upon performance criteria for the year ended December 31, 2021.
F2 Represents performance restricted stock units that were earned based upon performance criteria for the year ended December 31, 2021 and will vest in full once the Compensation and Management Development Committee (the "Committee") of the Board of Directors of Syneos Health, Inc. (the "Issuer") determines the attainment level of the performance goals for the year ended December 31, 2022, subject to continued employment.
F3 Represents performance restricted stock units that were earned based upon performance criteria for the year ended December 31, 2021 and will vest in full once the Committee determines the attainment level of the performance goals for the year ended December 31, 2023, subject to continued employment.